![N<sup>1</sup>-(3,5-Dimethoxyphenyl)-N<sup>2</sup>-(1-methylethyl)-N<sup>1</sup>-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine](https://static.cymitquimica.com/cas-image/327974-n-sup-1-sup-35-dimethoxyphenyl-n-sup-2-sup-1-methylethyl-n-sup-1-sup-3-1-methyl-1h-pyrazol-4-yl-6-quinoxalinyl-12-ethanediamine.png)
CAS: 1346242-81-6 - N<sup>1</sup>-(3,5-Dimethoxyphenyl)-N<sup>2</sup>-(1-methylethyl)-N<sup>1</sup>-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine
Formula:C25H30N6O2
InChI:InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
InChI key:InChIKey=OLAHOMJCDNXHFI-UHFFFAOYSA-N
SMILES:N1=CC(=NC=2C=C(C=CC12)N(C=3C=C(OC)C=C(OC)C3)CCNC(C)C)C=4C=NN(C4)C
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Erdafitinib REF: 4Z-K-031041CAS: 1346242-81-6 | - - - | To inquire | Tue 07 May 24 |
 | Erdafitinib REF: TM-T3726CAS: 1346242-81-6 | 99.07% | 46.00 €~558.00 € | Mon 13 May 24 |
 | Erdafitinib REF: 3D-FE76167CAS: 1346242-81-6 | Min. 95% | 95.00 €~586.00 € | Fri 17 May 24 |
 | Erdafitinib REF: TR-E594600CAS: 1346242-81-6 | - - - | 85.00 €~223.00 € | Tue 18 Jun 24 |
Ref: 4Z-K-031041
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 May 2024
Erdafitinib
CAS:1346242-81-6
Erdafitinib (JNJ-42756493) is a quinoxaline derivative compound, acts on FGFR1/2/3/4.
Formula:
C25H30N6O2
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
446.54
Ref: TM-T3726
| 5mg | 46.00 € | |
| 10mg | 69.00 € | |
| 25mg | 94.00 € | |
| 50mg | 149.00 € | |
| 100mg | 221.00 € | |
| 500mg | 558.00 € | |
| 1ml*10 (DMSO) | 50.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Erdafitinib
CAS:1346242-81-6
Fibroblast growth factor receptor inhibitor
Formula:
C25H30N6O2
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
446.54 g/mol
Ref: 3D-FE76167
| 10mg | 95.00 € | |
| 50mg | 184.00 € | |
| 100mg | 292.00 € | |
| 250mg | 406.00 € | |
| 500mg | 586.00 € |
Estimated delivery in United States, on Friday 17 May 2024
Erdafitinib
Controlled ProductCAS:1346242-81-6
Applications Erdafitinib is a fibroblast growth factor receptor inhibitor. References Perera, T. P. S., et …
Formula:
C25H30N6O2
Color and Shape:
Yellow Solid
Molecular weight:
446.54
Ref: TR-E594600
| 1mg | 85.00 € | |
| 10mg | 223.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
